SEC Form 4 · accession 0000899243-18-012754
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Paul North
Officer — Chief Information Officer
Period of report
May 11, 2018
Accepted (ET)
May 14, 2018 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 11, 2018 | M | 11,000 | $32.56 | A | 33,848 | D | |
| Common StockF2 | May 11, 2018 | S | 800 | $70.74 | D | 33,048 | D | |
| Common StockF3 | May 11, 2018 | S | 10,200 | $71.58 | D | 22,848 | D | |
| Common StockF4 | holding | — | — | — | 296 | I | Through 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $32.56 | May 11, 2018 | M | 11,000 | D | — | Jun 2, 2025 | Common Stock | 11,000 | 11,500 | D |
Explanation of responses
- F1Includes 594 shares held in an employee stock purchase plan account.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.62 to $70.84, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.10 to $71.85, inclusive.
- F4The information in this report is based on a plan statement dated as of March 31, 2018.
- F5The Stock Options are subject to time-based vesting conditions. 5,625 Stock Options vested on June 2, 2016, 5,625 Stock Options vested on June 2, 2017, and the remaining 11,250 Stock Options will vest in installments of 5,625 Stock Options on each of June 2, 2018 and June 2, 2019, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.